Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion type Assertion NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_head.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion wasGeneratedBy ECO_0000203 NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_provenance.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion wasDerivedFrom befree-20150227 NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_provenance.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion SIO_000772 17764565 NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_provenance.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion evidence source_evidence_literature NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_provenance.
- NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_assertion description "[The subset of triple-negative breast cancers (in other words, those with negative ER, PR, and HER-2/neu status) was positively associated with the methylation of the RIL/CDH13 panel and negatively associated with the HIN-1/RASSF1A panel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300409.RAD44n-JTc_XDwmR2veAtnHgN4BWM93ckjLEf82XLHlwA130_provenance.